Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
KROS · NASDAQ · Pharmaceutical Preparations
Keros Therapeutics (KROS) · oqro.io/stocks/KROS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$11.08−0.31 (−2.72%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director sold ~$4.7K of KROS shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director sold ~$1.6K of KROS shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director sold ~$5.3K of KROS shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director sold ~$663 of KROS shares in the open marketSourcePlanned sale · Planned for Nov 17, 2026 · Notice filed Nov 17, 2026
Director filed to sell about $5.8K of KROS stockSourcePlanned sale · Planned for Nov 17, 2026 · Notice filed Nov 17, 2026
Director filed to sell about $5.5K of KROS stockSourceInsider trade · Traded Nov 12, 2026 · Filed Nov 16, 2026
Director sold ~$5.6K of KROS shares in the open marketSourcePlanned sale · Planned for Nov 12, 2026 · Notice filed Nov 12, 2026
Director filed to sell about $5.6K of KROS stockSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 20, 2026
Officer sold ~$46K of KROS shares in the open marketSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 20, 2026
Officer sold ~$37K of KROS shares in the open marketSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 20, 2026
Director sold ~$5.7K of KROS shares in the open marketSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 20, 2026
Officer sold ~$13K of KROS shares in the open marketSourceInsider trade · Traded Jul 15, 2026 · Filed Jul 17, 2026
Director purchased ~$11K of KROS shares in the open marketSourceInsider trade · Traded Jun 15, 2026 · Filed Jun 17, 2026
Director purchased ~$10K of KROS shares in the open marketSourceInsider trade · Traded Jun 11, 2026 · Filed Jun 15, 2026
Director sold ~$5.5K of KROS shares in the open marketSourceInsider trade · Traded Jun 4, 2026 · Filed Jun 8, 2026
Director sold ~$28K of KROS shares in the open marketSourceInsider trade · Traded Jun 4, 2026 · Filed Jun 8, 2026
Director sold ~$28K of KROS shares in the open marketSourceInsider trade · Traded May 15, 2026 · Filed May 19, 2026
Director purchased ~$11K of KROS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in KROS for Q1 2026SourceInsider trade · Traded Apr 15, 2026 · Filed Apr 17, 2026
Director purchased ~$12K of KROS shares in the open marketSourceInsider trade · Traded Mar 9, 2026 · Filed Mar 11, 2026
Director purchased ~$22K of KROS shares in the open marketSourceInsider trade · Traded Feb 19, 2026 · Filed Feb 20, 2026
CEO sold ~$113K of KROS shares in the open marketSourceInsider trade · Traded Feb 18, 2026 · Filed Feb 20, 2026
CFO sold ~$77K of KROS shares in the open marketSourceInsider trade · Traded Feb 18, 2026 · Filed Feb 20, 2026
Officer sold ~$78K of KROS shares in the open marketSourceInsider trade · Traded Feb 18, 2026 · Filed Feb 20, 2026
Officer sold ~$63K of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 17, 2025
10% owner sold ~$40.6M of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 17, 2025
10% owner sold ~$19.9M of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 17, 2025
10% owner sold ~$21.8M of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 17, 2025
10% owner sold ~$2.76M of KROS shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 12, 2025
10% owner purchased ~$5.17M of KROS shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 12, 2025
10% owner purchased ~$3.2M of KROS shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 12, 2025
10% owner purchased ~$768K of KROS shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 12, 2025
10% owner purchased ~$174K of KROS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP no longer reported KROS for Q4 2024SourceInsider trade · Traded Jan 4, 2024 · Filed Jan 24, 2025
CFO sold ~$1.81M of KROS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed a new position in KROS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed a reduced position in KROS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Eventide Asset Management, LLC disclosed a reduced position in KROS for Q3 2024SourceInsider trade · Traded Aug 17, 2026 · Filed Aug 19, 2026
Director purchased ~$10K of KROS shares in the open marketSourceInsider trade · Traded Jun 4, 2026 · Filed Jun 5, 2026
Director sold ~$28K of KROS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a reduced position in KROS for Q4 2025SourceInsider trade · Traded Oct 15, 2025 · Filed Oct 15, 2025
10% owner sold ~$77.9M of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 15, 2025
10% owner sold ~$13.2M of KROS shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 15, 2025
10% owner sold ~$4.52M of KROS shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 12, 2025
10% owner purchased ~$154K of KROS shares in the open marketSource